These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9811893)

  • 1. The BRCA2 gene product functionally interacts with p53 and RAD51.
    Marmorstein LY; Ouchi T; Aaronson SA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13869-74. PubMed ID: 9811893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome stability, DNA recombination and the BRCA2 tumour suppressor.
    Venkitaraman AR
    Curr Opin Cell Biol; 2001 Jun; 13(3):338-43. PubMed ID: 11343905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51.
    Katagiri T; Saito H; Shinohara A; Ogawa H; Kamada N; Nakamura Y; Miki Y
    Genes Chromosomes Cancer; 1998 Mar; 21(3):217-22. PubMed ID: 9523196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2.
    Wong AK; Pero R; Ormonde PA; Tavtigian SV; Bartel PL
    J Biol Chem; 1997 Dec; 272(51):31941-4. PubMed ID: 9405383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair.
    Brugarolas J; Jacks T
    Nat Med; 1997 Jul; 3(7):721-2. PubMed ID: 9212093
    [No Abstract]   [Full Text] [Related]  

  • 6. RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein.
    Mizuta R; LaSalle JM; Cheng HL; Shinohara A; Ogawa H; Copeland N; Jenkins NA; Lalande M; Alt FW
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6927-32. PubMed ID: 9192668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.
    Davies AA; Masson JY; McIlwraith MJ; Stasiak AZ; Stasiak A; Venkitaraman AR; West SC
    Mol Cell; 2001 Feb; 7(2):273-82. PubMed ID: 11239456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G(2)/M checkpoint control.
    Chen CF; Chen PL; Zhong Q; Sharp ZD; Lee WH
    J Biol Chem; 1999 Nov; 274(46):32931-5. PubMed ID: 10551859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of BRCA1 and BRCA2: clues from their interacting proteins.
    Sharan SK; Bradley A
    J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):413-21. PubMed ID: 10819535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
    Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
    Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA2 and homologous recombination.
    Orelli BJ; Bishop DK
    Breast Cancer Res; 2001; 3(5):294-8. PubMed ID: 11597317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible function found for breast cancer genes.
    Marx G
    Science; 1997 Apr; 276(5312):531-2. PubMed ID: 9148411
    [No Abstract]   [Full Text] [Related]  

  • 13. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
    Yuan SS; Lee SY; Chen G; Song M; Tomlinson GE; Lee EY
    Cancer Res; 1999 Aug; 59(15):3547-51. PubMed ID: 10446958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
    Chen JJ; Silver D; Cantor S; Livingston DM; Scully R
    Cancer Res; 1999 Apr; 59(7 Suppl):1752s-1756s. PubMed ID: 10197592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA2-dependent and independent formation of RAD51 nuclear foci.
    Tarsounas M; Davies D; West SC
    Oncogene; 2003 Feb; 22(8):1115-23. PubMed ID: 12606939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
    Park JY; Singh TR; Nassar N; Zhang F; Freund M; Hanenberg H; Meetei AR; Andreassen PR
    Oncogene; 2014 Oct; 33(40):4803-12. PubMed ID: 24141787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.
    Chen PL; Chen CF; Chen Y; Xiao J; Sharp ZD; Lee WH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5287-92. PubMed ID: 9560268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous levels of Rad51 and Brca2 are required for homologous recombination and regulated by homeostatic re-balancing.
    Magwood AC; Malysewich MJ; Cealic I; Mundia MM; Knapp J; Baker MD
    DNA Repair (Amst); 2013 Dec; 12(12):1122-33. PubMed ID: 24210700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.
    Chen J; Silver DP; Walpita D; Cantor SB; Gazdar AF; Tomlinson G; Couch FJ; Weber BL; Ashley T; Livingston DM; Scully R
    Mol Cell; 1998 Sep; 2(3):317-28. PubMed ID: 9774970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.